SEI Investments’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.3K | Hold |
12,685
| – | – | ﹤0.01% | 2776 |
|
|
2025
Q1 | $27.9K | Hold |
12,685
| – | – | ﹤0.01% | 2722 |
|
|
2024
Q4 | $19.4K | Sell |
12,685
-2,118
| -14% | -$3.24K | ﹤0.01% | 2713 |
|
|
2024
Q3 | $29.5K | Buy |
14,803
+2,118
| +17% | +$4.22K | ﹤0.01% | 2656 |
|
|
2024
Q2 | $44.4K | Buy |
+12,685
| New | +$44.4K | ﹤0.01% | 2595 |
|
|
2023
Q2 | – | Sell |
-18,138
| Closed | -$27.4K | – | 2712 |
|
|
2023
Q1 | $27.4K | Buy |
+18,138
| New | +$27.4K | ﹤0.01% | 2651 |
|
|
2022
Q1 | – | Sell |
-394,473
| Closed | -$3.6M | – | 2616 |
|
|
2021
Q4 | $3.6M | Buy |
394,473
+68,523
| +21% | +$625K | 0.01% | 1311 |
|
|
2021
Q3 | $3.49M | Sell |
325,950
-25,061
| -7% | -$268K | 0.01% | 1266 |
|
|
2021
Q2 | $5.49M | Buy |
351,011
+78,053
| +29% | +$1.22M | 0.01% | 1028 |
|
|
2021
Q1 | $4.43M | Sell |
272,958
-142,258
| -34% | -$2.31M | 0.01% | 1084 |
|
|
2020
Q4 | $8.79M | Sell |
415,216
-49,022
| -11% | -$1.04M | 0.02% | 697 |
|
|
2020
Q3 | $6.88M | Buy |
464,238
+337,721
| +267% | +$5.01M | 0.02% | 721 |
|
|
2020
Q2 | $1.86M | Sell |
126,517
-1,184
| -0.9% | -$17.4K | 0.01% | 1301 |
|
|
2020
Q1 | $1.5M | Buy |
127,701
+95,120
| +292% | +$1.12M | 0.01% | 1271 |
|
|
2019
Q4 | $791K | Sell |
32,581
-504
| -2% | -$12.2K | ﹤0.01% | 1736 |
|
|
2019
Q3 | $590K | Buy |
+33,085
| New | +$590K | ﹤0.01% | 1806 |
|
|
2018
Q3 | – | Sell |
-29,560
| Closed | -$1.15M | – | 2896 |
|
|
2018
Q2 | $1.15M | Buy |
+29,560
| New | +$1.15M | ﹤0.01% | 1522 |
|
|
2017
Q2 | – | Sell |
-2,299
| Closed | -$34K | – | 3167 |
|
|
2017
Q1 | $34K | Buy |
2,299
+188
| +9% | +$2.78K | ﹤0.01% | 2221 |
|
|
2016
Q4 | $28K | Buy |
2,111
+6
| +0.3% | +$80 | ﹤0.01% | 2272 |
|
|
2016
Q3 | $36K | Buy |
+2,105
| New | +$36K | ﹤0.01% | 2145 |
|
|
2015
Q4 | – | Sell |
-11,483
| Closed | -$280K | – | 2597 |
|
|
2015
Q3 | $280K | Buy |
+11,483
| New | +$280K | ﹤0.01% | 1499 |
|